Trends in the incidence and mortality of transitional cell carcinoma of the bladder for the last four decades in the USA: a SEER-based analysis

Transitional cell carcinoma (TCC) accounts for around 95% of bladder cancers and is the 4th most common cancer among men and the tenth most common in women, in the US. There is a constant need to clarify current TCC incidence and mortality rates among different population groups for better clinical...

Full description

Saved in:
Bibliographic Details
Published in:BMC cancer 2019-01, Vol.19 (1), p.46-46, Article 46
Main Authors: Al-Husseini, Muneer J, Kunbaz, Ahmad, Saad, Anas M, Santos, João Vasco, Salahia, Sami, Iqbal, Marium, Alahdab, Fares
Format: Article
Language:English
Subjects:
Adenocarcinoma
African Americans
Bladder cancer
Carcinoma
Carcinoma, Transitional Cell - epidemiology
Carcinoma, Transitional Cell - history
Carcinoma, Transitional Cell - mortality
Care and treatment
Development and progression
Elderly
Female
Geriatrics
Health aspects
Health risk assessment
History, 20th Century
History, 21st Century
Humans
Incidence
Male
Mortality
Mutation
Patient outcomes
Population Surveillance
Practice guidelines (Medicine)
Retrospective Studies
SEER
SEER Program
Studies
Transitional cell carcinoma
Tumors
United States - epidemiology
Urinary Bladder Neoplasms - epidemiology
Urinary Bladder Neoplasms - history
Urinary Bladder Neoplasms - mortality
Womens health
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Transitional cell carcinoma (TCC) accounts for around 95% of bladder cancers and is the 4th most common cancer among men and the tenth most common in women, in the US. There is a constant need to clarify current TCC incidence and mortality rates among different population groups for better clinical practice guidelines. We aimed to describe the TCC incidence and incidence-based mortality by demographic and tumor-related characteristics over the last 40 years in the US. We obtained data from the SEER 18 registries to study TCC cases that were diagnosed between the years 1973 and 2014. We calculated incidence rates and incidence-based mortality rates in different demographic and tumor-related characteristics and expressed rates by 100,000 person-years. We then calculated the annual changes in incidence and incidence-based mortality rates and displayed them as annual percent changes (APCs). There were 182,114 patients with TCC between 1973 and 2014 in the United States. Overall incidence rates of TCC increased 0.16% (95% CI, 0.02-0.30, p = .02) per year over the study period. However, the incidence declined significantly since 2007; (95%CI,-1.89- -0.77, p 
ISSN:1471-2407
1471-2407
DOI:10.1186/s12885-019-5267-3